IBO: Inpainting-Based Occlusion to Enhance Explainable Artificial Intelligence Evaluation in Histopathology
This addresses the need for more reliable XAI evaluation in histopathology, which is crucial for cancer diagnosis, though it is an incremental improvement over existing occlusion methods.
The paper tackles the problem of inaccurate evaluation of explainable AI (XAI) methods in histopathology due to out-of-distribution artifacts from occlusion-based techniques, by introducing IBO, an inpainting-based occlusion strategy that improves perceptual fidelity by nearly 2x in LPIPS scores and increases XAI performance prediction precision from 42% to 71%.
Histopathological image analysis is crucial for accurate cancer diagnosis and treatment planning. While deep learning models, especially convolutional neural networks, have advanced this field, their "black-box" nature raises concerns about interpretability and trustworthiness. Explainable Artificial Intelligence (XAI) techniques aim to address these concerns, but evaluating their effectiveness remains challenging. A significant issue with current occlusion-based XAI methods is that they often generate Out-of-Distribution (OoD) samples, leading to inaccurate evaluations. In this paper, we introduce Inpainting-Based Occlusion (IBO), a novel occlusion strategy that utilizes a Denoising Diffusion Probabilistic Model to inpaint occluded regions in histopathological images. By replacing cancerous areas with realistic, non-cancerous tissue, IBO minimizes OoD artifacts and preserves data integrity. We evaluate our method on the CAMELYON16 dataset through two phases: first, by assessing perceptual similarity using the Learned Perceptual Image Patch Similarity (LPIPS) metric, and second, by quantifying the impact on model predictions through Area Under the Curve (AUC) analysis. Our results demonstrate that IBO significantly improves perceptual fidelity, achieving nearly twice the improvement in LPIPS scores compared to the best existing occlusion strategy. Additionally, IBO increased the precision of XAI performance prediction from 42% to 71% compared to traditional methods. These results demonstrate IBO's potential to provide more reliable evaluations of XAI techniques, benefiting histopathology and other applications. The source code for this study is available at https://github.com/a-fsh-r/IBO.